High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy
High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy
Recruiting · NCT06662994 · Registry updated 2025-07-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy | Diabetes Complications, Nutritional and Metabolic Diseases, autoimmune disease, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, glucose metabolism disease, immune system disorder, metabolic disease, retinal disorder, type 1 diabetes mellitus, type 2 diabetes mellitus, vascular disorder | Recruiting | Phase 4 | 2025-07-10 | NCT06662994 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Regeneron Pharmaceuticals | 238 |
| Retina Consultants of Orange County | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Retina Consultants of Orange County | Fullerton | United States | 13 |